High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
about
How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignanciesImproved treatment of multidrug-resistant bacterial infections: utility of clinical studies.Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature.Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU.Therapeutic drug monitoring of cefepime with micellar electrokinetic capillary chromatography: Assay improvement, quality assurance, and impact on patient drug levels.Monitoring of cefepime in human serum and plasma by micellar electrokinetic capillary chromatography: Improvement of sample preparation and validation by liquid chromatography coupled to mass spectrometry.Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.An MEKC assay for the therapeutic drug monitoring of cefepime.Not all β-lactams are equal regarding neurotoxicityCharacterizing Cefepime Neurotoxicity: A Systematic Review.Cefepime-induced neurotoxicity: a systematic review.Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem.Cefepime induced neurotoxicity: A case series and review of the literature.Cefepime-induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report.Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients.Antimicrobial Agents
P2860
Q34894900-C6D79453-3AAE-44F4-BF05-FB8714F93144Q35914849-7701D7D4-D3BC-4F3E-9817-98288358413AQ35960873-54432B82-9B23-46FC-825D-B5E7646D52EBQ38232197-2559452D-1E47-479D-ABE3-49D1B61806F6Q38232834-BDF6DA97-C767-4EA6-BD35-3C2C9D561B61Q38654209-016AB22C-54AC-4ACB-AB3C-B5CCF33E4C38Q38826267-A09B0599-8DA7-4134-A625-786F16AB52E7Q38896040-C9ACD2A8-74AC-4420-84E2-1B86835E240CQ38926404-8EA7F2E4-8BBE-4818-8081-211D1F0522A1Q39721085-C0F7D51E-81F7-4D9D-9882-F33DB8F108CEQ39808704-7F065360-D953-4BB3-897B-070B94CDB277Q40325696-E3462E60-9790-48F6-A389-9512E22FD415Q41564878-FDD17DD3-EB56-4638-BC8B-23199A29692FQ42232248-D300B2BC-709F-4CF2-BCD7-1CEA33544975Q42254941-082FA69C-6C7D-42C6-9739-87F819B1F7E3Q42379657-8FBAE979-A78C-4C4F-966E-4F51ACE9D3ACQ42702123-1D4EF83E-FFD2-4092-81C0-2C6F84492E48Q43915417-4EFDB641-9827-4295-B77D-144E8439D8B1Q45171686-22F26838-89BB-4E62-B81F-5DC3AB275326Q47136833-7AEB6D7C-0D91-4031-94A8-58D5A55BDECCQ47281419-FC532063-F941-439A-BB17-92B7A3936C26Q51014621-75ADECBD-1A28-4AAA-A5B3-9EB1206E611BQ57549163-3851F838-2174-4D3A-BB7B-6CDC6F0E2548
P2860
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High cefepime plasma concentra ...... impairment of renal function.
@ast
High cefepime plasma concentra ...... impairment of renal function.
@en
High cefepime plasma concentra ...... impairment of renal function.
@nl
type
label
High cefepime plasma concentra ...... impairment of renal function.
@ast
High cefepime plasma concentra ...... impairment of renal function.
@en
High cefepime plasma concentra ...... impairment of renal function.
@nl
prefLabel
High cefepime plasma concentra ...... impairment of renal function.
@ast
High cefepime plasma concentra ...... impairment of renal function.
@en
High cefepime plasma concentra ...... impairment of renal function.
@nl
P2093
P2860
P50
P356
P1476
High cefepime plasma concentra ...... impairment of renal function.
@en
P2093
P2860
P304
P356
10.1128/AAC.01595-08
P407
P577
2010-07-12T00:00:00Z